An Evaluation of a Flippin' Pain Seminar Series

Status Completed

Clinical Trial Summary

The goal of this study is to evaluate a chronic pain seminar series, Flippin' Pain. The primary aim is to examine the impact of the seminars on attendees' beliefs and perceptions of the following with regards to chronic pain: medications, surgery, physical activity, and scans. A secondary aim is to examine attendees' experience of the seminar events. Seminar attendees included people with chronic pain and on an NHS waiting list for treatment, people with chronic pain and not on an NHS waiting list for treatment, healthcare professionals and non-healthcare professionals without chronic pain.

Clinical Trial Description

Chronic pain is defined as pain that continues for more than twelve weeks despite treatment. Chronic pain can be highly debilitating and have a devastating impact on an individual's mental and physical health and social aspects of their life. Poor understanding of chronic pain is widespread and can greatly reduce a) an individual's ability to manage their condition and b) the clinician's ability to treat the condition successfully. Educational interventions are therefore recommended. Flippin' Pain is a public health campaign that aims to improve understanding of chronic pain. In February/March 2022, as part of the Flippin' Pain campaign, the Scottish government and NHS contracted Connect Health (TM) to deliver a series of 3 seminars in Scotland focused on pain science education. It was part of the Scottish Government 'Waiting Well' initiative and specifically targeted people on waiting lists for pain and musculoskeletal services in Scotland, although non-NHS individuals could also join including health professionals. Everyone who attended the seminars was asked if they would be happy to be contacted by the organisers as part of an evaluation of this event series. Evaluation questionnaires were completed by 442 participants. This study will therefore be a secondary data analysis of this anonymous questionnaire data set to a). examine the impact of the seminars on attendees' beliefs and perceptions of chronic pain focusing on views towards medications, surgery, physical activity, and scans, and b). examine attendees' experience of the seminar events themselves. The quantitative data collected from the questionnaires will be analysed using descriptive statistics. The qualitative free-text data collected from the questionnaires will be analysed using thematic analysis following Braun and Clarke's Framework. ;

Study Design

Related Conditions & MeSH terms

Chronic Pain

Clinical Trial Details

NCT number	NCT05724667
Study type	Observational
Source	Teesside University
Contact
Status	Completed
Phase
Start date	February 15, 2022
Completion date	April 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01659073` - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation	N/A
Recruiting	`NCT05914311` - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration	N/A
Recruiting	`NCT05422456` - The Turkish Version of Functional Disability Inventory
Enrolling by invitation	`NCT05422443` - The Turkish Version of Pain Coping Questionnaire
Completed	`NCT05057988` - Virtual Empowered Relief for Chronic Pain	N/A
Completed	`NCT04385030` - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury	N/A
Recruiting	`NCT06206252` - Can Medical Cannabis Affect Opioid Use?
Completed	`NCT05103319` - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed	`NCT03687762` - Back on Track to Healthy Living Study	N/A
Completed	`NCT04171336` - Animal-assisted Therapy for Children and Adolescents With Chronic Pain	N/A
Completed	`NCT03179475` - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury	Phase 4
Completed	`NCT03418129` - Neuromodulatory Treatments for Pain Management in TBI	N/A
Completed	`NCT03268551` - MEMO-Medical Marijuana and Opioids Study
Recruiting	`NCT06060028` - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain	N/A
Recruiting	`NCT06204627` - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain	N/A
Completed	`NCT05496205` - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers	Phase 1
Completed	`NCT00983385` - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics	Phase 3
Recruiting	`NCT05118204` - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization	Phase 4
Terminated	`NCT03538444` - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder	N/A
Not yet recruiting	`NCT05812703` - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.